Yutai Li

Yutai Li has extensive work experience in the field of pharmaceuticals and research. Yutai is currently a Senior Director at Allorion Therapeutics, a position they have held since November 2021. Prior to that, they worked at Merck for 17 years, starting as a Principal Scientist in November 2004 and ending in September 2021.

Before joining Merck, Yutai Li worked at the University of North Carolina at Chapel Hill as a Mass Spectrometry Facility Manager from 2002 to 2004. In this role, they maintained the facility and instruments, collaborated on research projects in biomarkers, cancer, and nutrition, and supervised and trained graduate students and postdocs.

Yutai'sprevious experience includes working as an Associate Principal Scientist at Schering-Plough Research Institute from 2001 to 2002 and as a Section Chemist at DuPont from 1995 to 2001. In these roles, they conducted environmental studies, monitored research projects, and participated in regulatory dossier preparation.

Yutai Li holds a Doctor of Philosophy (Ph.D.) degree from North Carolina State University. Additionally, Yutai Li obtained a Regulatory Affairs Certificate from Lehigh University in 2010. No specific information regarding the duration or field of study for the Ph.D. program is provided.